Does BREXPIPRAZOLE Cause Extrapyramidal disorder? 179 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 179 reports of Extrapyramidal disorder have been filed in association with BREXPIPRAZOLE (Rexulti). This represents 1.4% of all adverse event reports for BREXPIPRAZOLE.
179
Reports of Extrapyramidal disorder with BREXPIPRAZOLE
1.4%
of all BREXPIPRAZOLE reports
2
Deaths
34
Hospitalizations
How Dangerous Is Extrapyramidal disorder From BREXPIPRAZOLE?
Of the 179 reports, 2 (1.1%) resulted in death, 34 (19.0%) required hospitalization, and 7 (3.9%) were considered life-threatening.
Is Extrapyramidal disorder Listed in the Official Label?
Yes, Extrapyramidal disorder is listed as a known adverse reaction in the official FDA drug label for BREXPIPRAZOLE.
What Other Side Effects Does BREXPIPRAZOLE Cause?
Weight increased (1,589)
Product use in unapproved indication (1,188)
Off label use (937)
Akathisia (807)
Drug ineffective (730)
Tardive dyskinesia (558)
Tremor (552)
Anxiety (475)
Product use issue (434)
Suicidal ideation (427)
What Other Drugs Cause Extrapyramidal disorder?
RISPERIDONE (2,613)
ARIPIPRAZOLE (1,424)
OLANZAPINE (1,269)
QUETIAPINE (920)
HALOPERIDOL (838)
PALIPERIDONE (740)
CLOZAPINE (513)
LITHIUM (411)
METOCLOPRAMIDE (394)
LORAZEPAM (279)
Which BREXPIPRAZOLE Alternatives Have Lower Extrapyramidal disorder Risk?
BREXPIPRAZOLE vs BREXUCABTAGENE AUTOLEUCEL
BREXPIPRAZOLE vs BRIGATINIB
BREXPIPRAZOLE vs BRILINTA
BREXPIPRAZOLE vs BRILIQUE
BREXPIPRAZOLE vs BRIMONIDINE